Candesartan-Induced Enteropathy That Mimics Celiac Disease in a 90-Year-Old Patient

Sprue-like enteropathy (SLE) is a clinical syndrome similar to celiac disease and has been associated with the use of various angiotensin receptor blockers (ARBs), a class of medications frequently used in the management of hypertension. Currently, there has only been one documented case report which has observed this occurrence with the use of the ARB candesartan. A 90-year-old female patient presented with chronic diarrhea and weight loss of unclear etiology. Diagnostic esophagogastroduodenoscopy and ileocolonoscopy were macroscopically unremarkable, but histological samples revealed complete villous atrophy, chronic mucosal inflammation, and intraepithelial T-lymphocytic infiltration. However, serological studies could not confirm celiac disease as a cause for the patient’s symptoms of malabsorption. After exclusion of other intestinal inflammation etiologies with noted ongoing candesartan use, the diagnosis of SLE was made, and candesartan therapy was discontinued. Additionally, we decided to initiate a lactose-free diet. Clinical remission was achieved without any recurrences. Candesartan is a commonly prescribed therapeutic agent in the treatment of hypertension. Our case underlines the importance of considering it as a potential cause for unexplained symptoms of malabsorption.

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• Extent: Online-Ressource
• Language: Englisch

References and Relationships

• Bibliographic citation: Candesartan-Induced Enteropathy That Mimics Celiac Disease in a 90-Year-Old Patient ; volume:17 ; number:1 ; year:2023 ; pages:185-191 ; extent:7 ; Case reports in gastroenterology ; 17, Heft 1 (2023), 185-191 (gesamt 7)

Contributors, Places and Time

• Creator: Holtgrewe, Lydia ; Dippel, Harald ; Weckauf, Helgard ; Linnemüller, Stephan ; Schuppert, Frank

Further information

• DOI: 10.1159/000529003
• URN: urn:nbn:de:101:1-2024010323381119792426
• Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 15.08.2025, 7:20 AM CEST